Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides - PubMed (original) (raw)
Case Reports
. 1992 Mar;28A(3 Pt 1):161-7.
doi: 10.1007/BF02631086.
Affiliations
- PMID: 1582990
- DOI: 10.1007/BF02631086
Case Reports
Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides
K Kaltoft et al. In Vitro Cell Dev Biol. 1992 Mar.
Abstract
From a plaque biopsy of a patient with mycosis fungoides, two different continuous cell lines were established by including both IL-2 and IL-4 in the culture medium. Both continuous cell lines appeared with characteristic chromosome markers after approximately 40 cell population doublings. The initial karyotype recognized in T cells from the skin biopsy was 46,XY and the karyotypes of the continuous cell strains were 46,XY, -18, + i(18q) and another with multiple chromosome aberrations as described in Sezary T-cell leukemia. Phenotyping with monoclonal antibodies and T-cell receptor analysis indicates that the latter cell strain represents a minority of T-cells in the plaque. Due to its many chromosomal aberrations it probably represents the malignant cell, which may be a central cell in the immune stimulation taking place in the skin.
Similar articles
- Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Jawed SI, et al. J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. J Am Acad Dermatol. 2014. PMID: 24438969 Review. - Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--part II.
Safai B. Safai B. Clin Bull. 1977;7(4):140-5. Clin Bull. 1977. PMID: 147147 No abstract available. - Current problems in mycosis fungoides and Sézary syndrome.
Winkelmann RK, Caro WA. Winkelmann RK, et al. Annu Rev Med. 1977;28:251-69. doi: 10.1146/annurev.me.28.020177.001343. Annu Rev Med. 1977. PMID: 140621 Review. No abstract available. - Lymphomatoid papulosis associated with mycosis fungoides: clinicopathological and molecular studies of 12 cases.
Gallardo F, Costa C, Bellosillo B, Solé F, Estrach T, Servitje O, García-Muret MP, Barranco C, Serrano S, Pujol RM. Gallardo F, et al. Acta Derm Venereol. 2004;84(6):463-8. doi: 10.1080/00015550410016949. Acta Derm Venereol. 2004. PMID: 15844638 - Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
Wood GS, Hong SR, Sasaki DT, Abel EA, Hoppe RT, Warnke RA, Morhenn VB. Wood GS, et al. J Am Acad Dermatol. 1990 Apr;22(4):602-7. doi: 10.1016/0190-9622(90)70080-2. J Am Acad Dermatol. 1990. PMID: 1690762
Cited by
- Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines.
Netchiporouk E, Gantchev J, Tsang M, Thibault P, Watters AK, Hughes JM, Ghazawi FM, Woetmann A, Ødum N, Sasseville D, Litvinov IV. Netchiporouk E, et al. Oncotarget. 2017 Oct 7;8(56):95981-95998. doi: 10.18632/oncotarget.21619. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221181 Free PMC article. - Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.
Woetmann A, Lovato P, Eriksen KW, Krejsgaard T, Labuda T, Zhang Q, Mathiesen AM, Geisler C, Svejgaard A, Wasik MA, Ødum N. Woetmann A, et al. Blood. 2007 Apr 15;109(8):3325-32. doi: 10.1182/blood-2006-04-017863. Epub 2006 Dec 19. Blood. 2007. PMID: 17179233 Free PMC article. - BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition.
Kim SR, Lewis JM, Cyrenne BM, Monico PF, Mirza FN, Carlson KR, Foss FM, Girardi M. Kim SR, et al. Oncotarget. 2018 Jun 26;9(49):29193-29207. doi: 10.18632/oncotarget.25670. eCollection 2018 Jun 26. Oncotarget. 2018. PMID: 30018745 Free PMC article. - Key Role of Reactive Oxygen Species (ROS) in Indirubin Derivative-Induced Cell Death in Cutaneous T-Cell Lymphoma Cells.
Soltan MY, Sumarni U, Assaf C, Langer P, Reidel U, Eberle J. Soltan MY, et al. Int J Mol Sci. 2019 Mar 7;20(5):1158. doi: 10.3390/ijms20051158. Int J Mol Sci. 2019. PMID: 30866411 Free PMC article. - Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.
Litvinov IV, Cordeiro B, Fredholm S, Ødum N, Zargham H, Huang Y, Zhou Y, Pehr K, Kupper TS, Woetmann A, Sasseville D. Litvinov IV, et al. Cell Cycle. 2014;13(18):2975-82. doi: 10.4161/15384101.2014.947759. Cell Cycle. 2014. PMID: 25486484 Free PMC article.
References
- J Invest Dermatol. 1990 Jul;95(1):4-8 - PubMed
- J Am Acad Dermatol. 1980 Feb;2(2):89-106 - PubMed
- Br J Dermatol. 1986 Jun;114(6):677-84 - PubMed
- J Clin Invest. 1982 Dec;70(6):1205-15 - PubMed
- Lancet. 1981 Aug 8;2(8241):283-5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials